December 7, 2025 · Form 4 insider transaction
INGRAM DOUGLAS S bought 73,001 shares of Sarepta Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The Reporting Person was granted Performance Units, as described in the Company's 2018 Equity Incentive Plan. The Performance Units are subject to service- and performance-based vesting criteria.